Impact of ultra-processed foods on rheumatic diseases
Impact of Ultra-processed Foods in a Population of Patients With Chronic Rheumatic Diseases (Rheumatoid Arthritis, Spondyloarthritis, Osteoarthritis).
This study looks at how eating ultra-processed foods might affect people with chronic rheumatic diseases like rheumatoid arthritis and osteoarthritis to see if it makes their symptoms worse.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 240 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Lyon) |
| Trial ID | NCT06776965 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the consumption patterns of ultra-processed foods (UPF) among patients with chronic rheumatic diseases such as rheumatoid arthritis, spondyloarthritis, and osteoarthritis. It will assess the relationship between UPF consumption and disease activity using various evaluation tools, including dietary questionnaires and disease activity scores. The study seeks to understand whether UPF consumption is linked to increased risk or exacerbation of these conditions, potentially through mechanisms affecting gut microbiota and immune responses.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old with a diagnosis of chronic rheumatic diseases.
Not a fit: Patients with two simultaneous rheumatic diseases or those under judicial protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into dietary modifications that may help manage or reduce the severity of rheumatic diseases.
How similar studies have performed: While the specific relationship between UPF and rheumatic diseases is not extensively studied, there is emerging evidence linking diet to inflammatory conditions, suggesting potential for meaningful findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * chronic rheumatic disease (Rheumatoid arthritis, spondyloarthritis, osteoarthritis) * ability to perform questionnaires Exclusion Criteria: * Judicial protection measure * Refusal to participate in the study * Suffering from 2 rheumatic disease simultaneously
Where this trial is running
Lyon
- Edouard Herriot Hospital — Lyon, France (Recruiting)
Study contacts
- Principal investigator: Maxime AUROUX, MD — Hôpital Edouard Herriot
- Study coordinator: Maxime AUROUX, MD
- Email: Maxime.auroux@chu-lyon.fr
- Phone: +33472117479
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.